What is EyePoint, Inc. 's short- term investments?

EyePoint, Inc. (EYPT) reported short- term investments of $144.83M in Q1 2026.

How has EyePoint, Inc. 's short- term investments changed year-over-year?

EyePoint, Inc. 's short- term investments decreased by 37.8% year-over-year, from $233.04M to $144.83M.

EyePoint, Inc. EYPT Short- term Investments

Short- term Investments at other companies

Merck & Co.MRK

——

Regeneron PharmaceuticalsREGN

——

Tarsus Pharmaceuticals, Inc.TARS

——

Denali Therapeutics Inc.DNLI

——

United TherapeuticsUTHR

——

Other financials

Income statement

See full

Revenue$696.0K-97.2%

Gross profit$9.8M-30.1%

Operating income-$87.2M-78.6%

Net income-$84.8M-87.7%

EPS (diluted)-$0.99-52.3%

Balance sheet

See full

Cash & equivalents$77.7M-8.7%

Total debt$22.3M-7.3%

Total equity$230.5M-22.8%

Total assets$288.2M-20.5%

Cash flow

See full

Operating cash flow-$80.5M-51.6%

CapEx$997.0K+261%

Free cash flow-$81.5M-52.7%

Valuation

See full

Market cap$1.21B+108%

Enterprise value$1.15B+122%

P/S158.5×+148×

Profitability

See full

Operating margin-3,700.9%-4,042pp

Net margin-3,566.6%-3,874pp

FCF margin-3,565.9%-3,884pp

Returns & leverage

See full

Return on equity-102.7%+1,157pp

Debt / equity0.1×0.0×

Current ratio6.7×-1.2×

Where this comes from

Reported directly by EyePoint, Inc. in its filing.

Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.

The official record: EyePoint, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about EyePoint, Inc. 's short- term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is EyePoint, Inc. 's short- term investments?: EyePoint, Inc. (EYPT) reported short- term investments of $144.83M in Q1 2026.
How has EyePoint, Inc. 's short- term investments changed year-over-year?: EyePoint, Inc. 's short- term investments decreased by 37.8% year-over-year, from $233.04M to $144.83M.